StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.39−0.03 (-0.39%)

Close on Nov 17, 2026Market cap $241.88MP/E –Yield –

Lifecore Biomedical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Lifecore Biomedical's revenue for the twelve months ending May 25, 2025 was $128.87M, up 0.5% year over year. For fiscal 2025 it was $128.87M, up 0.5% from the year before. Over ten years it grew -13.3% a year on average. The highest annual figure on record is $557.56M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2025May 25, 2025$128.87M+0.5%
FY2024May 26, 2024$128.26M+24.2%
FY2023May 28, 2023$103.27M-7.2%
FY2022May 29, 2022$111.27M+10.3%
FY2021May 30, 2021$100.87M-37.0%
FY2020May 31, 2020$160.07M-71.3%
FY2019May 26, 2019$557.56M+6.4%
FY2018May 27, 2018$524.23M+11.6%
FY2017May 28, 2017$469.78M-1.5%
FY2016May 29, 2016$476.92M-11.6%
FY2015May 31, 2015$539.26M+13.1%
FY2014May 25, 2014$476.81M+7.9%
FY2013May 26, 2013$441.71M+39.1%
FY2012May 27, 2012$317.55M+14.8%
FY2011May 29, 2011$276.73M+16.2%
FY2010May 30, 2010$238.22M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ2 2025May 25, 2025$36.44M-3.8%
Q3 FY2025CQ1 2025Feb 23, 2025$35.15M-1.5%
Q2 FY2025CQ4 2024Nov 24, 2024$32.56M+8.0%
Q1 FY2025CQ3 2024Aug 25, 2024$24.71M+0.7%
Q4 FY2024CQ2 2024May 26, 2024$37.89M+21.6%
Q3 FY2024CQ1 2024Feb 25, 2024$35.70M+34.5%
Q2 FY2024CQ4 2023Nov 26, 2023$30.15M+37.9%
Q1 FY2024CQ3 2023Aug 27, 2023$24.52M+3.4%
Q4 FY2023CQ2 2023May 28, 2023$31.15M+10.8%
Q3 FY2023CQ1 2023Feb 26, 2023$26.54M-24.7%
Q2 FY2023CQ4 2022Nov 27, 2022$21.86M-14.6%
Q1 FY2023CQ3 2022Aug 28, 2022$23.72M+6.2%
Q4 FY2022CQ2 2022May 29, 2022$28.11M-37.4%
Q3 FY2022CQ1 2022Feb 27, 2022$35.23M+26.7%
Q2 FY2022CQ4 2021Nov 28, 2021$25.60M+7.6%
Q1 FY2022CQ3 2021Aug 29, 2021$22.33M-1.5%
Q4 FY2021CQ2 2021May 30, 2021$44.92M-71.2%
Q3 FY2021CQ1 2021Feb 28, 2021$27.81M-81.8%
Q2 FY2021CQ4 2020Nov 29, 2020$23.79M-83.3%
Q1 FY2021CQ3 2020Aug 30, 2020$22.68M-83.7%
Q4 FY2020CQ2 2020May 31, 2020$156.13M+2.2%
Q3 FY2020CQ1 2020Feb 23, 2020$152.93M-1.7%
Q2 FY2020CQ4 2019Nov 24, 2019$142.59M+14.5%
Q1 FY2020CQ3 2019Aug 25, 2019$138.71M+11.3%
Q4 FY2019CQ2 2019May 26, 2019$152.78M+8.3%
Q3 FY2019CQ1 2019Feb 24, 2019$155.55M+7.3%
Q2 FY2019CQ4 2018Nov 25, 2018$124.56M+1.7%
Q1 FY2019CQ3 2018Aug 26, 2018$124.67M+7.7%
Q4 FY2018CQ2 2018May 27, 2018$141.08M+16.3%
Q3 FY2018CQ1 2018Feb 25, 2018$144.91M+12.1%
Q2 FY2018CQ4 2017Nov 26, 2017$122.46M+11.2%
Q1 FY2018CQ3 2017Aug 27, 2017$115.78M+6.2%
Q4 FY2017CQ2 2017May 28, 2017$121.27M-10.4%
Q3 FY2017CQ1 2017Feb 26, 2017$129.29M-0.5%
Q2 FY2017CQ4 2016Nov 27, 2016$110.16M–
Q1 FY2017CQ3 2016Aug 28, 2016$109.06M–
Q4 FY2016CQ2 2016May 29, 2016$135.31M–
Q3 FY2016CQ1 2016Feb 28, 2016$129.99M–

More Lifecore Biomedical figures

See a number that looks wrong?